ELEVATION ONCOLOGY INC (ELEV) Stock Income Statement
NASDAQ:ELEV - Nasdaq - US28623U1016 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 45.67M | 44.70M | 40.34M | 94.55M | 32.05M | |||
| Research and Development | 29.46M | 28.60M | 25.43M | 78.72M | 23.60M | |||
| Selling, General, and Administrative Expenses | 16.21M | 16.11M | 14.90M | 15.83M | 8.45M | |||
| Operating Income | -45.67M | -44.70M | -40.34M | -94.55M | -32.05M | |||
| Interest Income/Expense | 1.10M | 1.20M | -4.20M | -1.50M | N/A | |||
| Other Income/Expense | N/A | N/A | 3.97M | 990.00K | 10.00K | |||
| Non Recurring Items | -3.38M | -942.00K | -5.11M | N/A | N/A | |||
| Income Before Taxes | -47.95M | -44.44M | -45.67M | -95.06M | -32.04M | |||
| Income Tax | 38.00K | 43.00K | 30.00K | 30.00K | N/A | |||
| Net Income | -47.99M | -44.48M | -45.70M | -95.08M | -32.04M | |||
| EBITDA | -45.66M | -44.68M | -40.30M | -94.52M | -32.03M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.81 | -0.78 | -1.34 | -4.09 | -2.64 | |||
| Non GAAP EPS | -0.82 | -0.81 | -1.53 | -4.09 | N/A | |||
| Statistics | ||||||||
All data in USD